Ekso Bionics Holdings Stock Alpha and Beta Analysis

EKSO Stock  USD 0.42  0.04  8.70%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Ekso Bionics Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Ekso Bionics over a specified time horizon. Remember, high Ekso Bionics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Ekso Bionics' market risk premium analysis include:
Beta
(1.12)
Alpha
(0.52)
Risk
6.62
Sharpe Ratio
(0.07)
Expected Return
(0.49)
Please note that although Ekso Bionics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Ekso Bionics did 0.52  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Ekso Bionics Holdings stock's relative risk over its benchmark. Ekso Bionics Holdings has a beta of 1.12  . As the market becomes more bullish, returns on owning Ekso Bionics are expected to decrease slowly. On the other hand, during market turmoil, Ekso Bionics is expected to outperform it slightly. As of the 14th of March 2025, Book Value Per Share is likely to drop to 0.60. In addition to that, Tangible Book Value Per Share is likely to drop to 0.36.

Enterprise Value

23.1 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Ekso Bionics Backtesting, Ekso Bionics Valuation, Ekso Bionics Correlation, Ekso Bionics Hype Analysis, Ekso Bionics Volatility, Ekso Bionics History and analyze Ekso Bionics Performance.

Ekso Bionics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Ekso Bionics market risk premium is the additional return an investor will receive from holding Ekso Bionics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ekso Bionics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Ekso Bionics' performance over market.
α-0.52   β-1.12

Ekso Bionics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Ekso Bionics' Buy-and-hold return. Our buy-and-hold chart shows how Ekso Bionics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Ekso Bionics Market Price Analysis

Market price analysis indicators help investors to evaluate how Ekso Bionics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ekso Bionics shares will generate the highest return on investment. By understating and applying Ekso Bionics stock market price indicators, traders can identify Ekso Bionics position entry and exit signals to maximize returns.

Ekso Bionics Return and Market Media

The median price of Ekso Bionics for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 0.61 with a coefficient of variation of 16.35. The daily time series for the period is distributed with a sample standard deviation of 0.1, arithmetic mean of 0.59, and mean deviation of 0.07. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of 15599 shares by Steven Sherman of Ekso Bionics subject to Rule 16b-3
01/15/2025
2
Rehabilitation Equipment Market Analysis Report 2025-2030 Innovations in Robotic-Assisted Rehab, Virtual Reality Therapy, and Smart Wearables Fueling Growth
01/22/2025
3
Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 Conference Call to Follow
02/24/2025
4
Ekso Bionics Holdings Inc expected to post a loss of 8 cents a share - Earnings Preview - TradingView
02/28/2025
5
Ekso Bionics Holdings Inc Q4 2024 Earnings Call Highlights Record Revenue and Strategic ...
03/04/2025
6
Ekso Bionics Holdings, Inc. Just Reported And Analysts Have Been Cutting Their Estimates
03/06/2025
7
StockNews.com Initiates Coverage on Ekso Bionics
03/13/2025

About Ekso Bionics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Ekso or other stocks. Alpha measures the amount that position in Ekso Bionics Holdings has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2024 2025 (projected)
Dividend Yield0.130.11
Price To Sales Ratio0.690.65

Ekso Bionics Upcoming Company Events

As portrayed in its financial statements, the presentation of Ekso Bionics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ekso Bionics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Ekso Bionics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Ekso Bionics. Please utilize our Beneish M Score to check the likelihood of Ekso Bionics' management manipulating its earnings.
26th of March 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Ekso Bionics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:
Ekso Bionics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Ekso Bionics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Ekso Bionics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...